In a large population-based study in which either interferon-β (IFNβ) or glatiramer acetate (GA) were used in 202 pregnancies fathered by 141 men with MS, no difference in mean birth weight and gestational age was found compared with fathers without MS.9 Here, IFNB1 is linked to myeloid sarcoma.